Huge sales of OTC analgesics are generated in Egypt on an annual basis and 2019 was no exception as further strong increases in demand were seen. The main reason for this situation is that self-medication is extremely common in Egypt, with the majority of people preferring to consult a pharmacist when facing discomfort or the initial symptoms of mild and moderate illness.
All categories of OTC analgesics registered positive growth in Egypt during 2019, with very strong growth in demand recorded in most categories. As the country’s economy continues to improve, with rising spending due to low levels of pressure on household budgets, some analgesics categories are facing slower growth in demand than in previous years.
Analgesics is set to continue registering consistently strong positive sales growth throughout the forecast period. Among the main drivers of categories dynamic performance are Egypt’s growing population, including strong increases expected in the numbers of babies and children among the country’s population.
GSK Consumer Healthcare remained the leading player in analgesics in 2019. The company offers three of the four leading brands in the category: Panadol, Cataflam and Voltaren.
Abbott Laboratories maintain second position in analgesics in 2019 due to the enduring popularity of its ibuprofen brand Brufen, which remains the leading brand of analgesics in Egypt. In particular, Brufen is extremely popular in its paediatric variant, which is very commonly given to children by their parents.
Novartis Egypt maintained third position in analgesics in 2019 due to the popularity of its brand Catafast, which is the second leading name in diclofenac. It should also be noted that the leading diclofenac brand in Egypt, Cataflam, is still produced by Novartis EG despite being marketed by GSK Consumer Healthcare following the latter company’s acquisition of the rights to the brand.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Egypt with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Egypt, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Egypt market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.